Clinical Trial: Efficacy of Nebulized rhIFN-α1b plus Bairui Granules in Children with Infectious Mononucleosis and Impact on Serum Immune Factors (China)

Posted On: 2026-10-13

China, Oct. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Nebulized rhIFN-α1b plus Bairui Granules in Children with Infectious Mononucleosis and Impact on Serum Immune Factors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134200

Registration Time: 2026/10/12

Type: Interventional study

Primary Sponsor: Jiangjin Central Hospital of Chongqing

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335594

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy of Nebulized rhIFN-α1b plus Bairui Granules in Children with Infectious Mononucleosis and Impact on Serum Immune Factors (China)